gpapi vs ImmuniWeb® Neuron Mobile: 2026 Comparison
gpapi is a free mobile app security tool. ImmuniWeb® Neuron Mobile is a commercial mobile app security tool by ImmuniWeb. Compare features, ratings, integrations, and community reviews side by side to find the best mobile app security fit for your security stack.
CST VerdictBased on our analysis of NIST CSF 2.0 coverage, company size fit, deployment model, here is our conclusion:
Mobile app security teams building or testing Android applications need gpapi if they're automating Google Play Store interaction testing at scale; the Node library mimics actual Nexus device behavior rather than relying on mocked APIs, which catches real-world integration failures that static analysis misses. With 280 GitHub stars and zero licensing friction, it's lightweight enough for CI/CD pipelines where teams can't justify commercial mobile testing platforms. Skip this if your threat model centers on runtime app protection or user-facing vulnerability detection; gpapi is purely a development-time testing tool for Play Store API integration, not a runtime mobile defense layer.
Mobile app teams in startups and mid-market companies need ImmuniWeb® Neuron Mobile because it catches vulnerabilities in both Android and iOS builds without requiring source code access, letting you scan third-party SDKs and obfuscated code that static analyzers miss. The AI-driven DAST component handles runtime behavior testing across both platforms from a single cloud console, which cuts the typical two-tool sprawl in half. Skip this if you're an enterprise already committed to heavyweight SAST platforms with dedicated mobile modules; Neuron trades some configuration depth for speed and is built for teams that need results in days, not quarters.
